Verrica Pharmaceuticals Inc.: Form 8-K, filed Dec 9, 2024
Filed with the SEC on Dec 9, 2024 and accepted by EDGAR at Dec 9, 2024, 16:10 ET.
Items reported
- Item 5.02 Departure or appointment of officers or directors
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001193125-24-273406. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.